Gov. Tim Walz Promotes Minnesota on Trade Mission to United Kingdom, Finland
![](https://medicalalley.org/wp-content/uploads/2018/09/MAA-and-MN-300x150.png)
Department of Defense Medical Team to Support Staff at HCMC and St. Cloud Hospital
![](https://medicalalley.org/wp-content/uploads/2020/04/centracare-300x71.jpeg)
FDA Clears Medtronic’s PillCam System for Remote Endoscopy Procedures
![](https://medicalalley.org/wp-content/uploads/2021/03/medtronic-logo-300x109.png)
Aurora Pharmaceuticals Launches Scholarship Program at Texas Tech
![](https://medicalalley.org/wp-content/uploads/2018/02/aurora.png)
Hardtech Innovation Center mHUB Announces Portfolio Teams of Premier MedTech Accelerator Cohort
![](https://medicalalley.org/wp-content/uploads/2021/11/mHub-logo-300x77.png)
Aquadex SmartFlow® System by Nuwellis Selected as a 2021 R&D 100 Awards Winner
![](https://medicalalley.org/wp-content/uploads/2021/04/nuwellis_logo_transparent-300x78.png)
Pear Therapeutics Picks Up Another $50M Ahead of Going Public Through SPAC Merger
![](https://medicalalley.org/wp-content/uploads/2021/04/Screen-Shot-2021-04-01-at-12.19.03-PM-300x142.png)
Marani Health closes $7.6M seed funding round, adds strategic investor and board member
![](https://medicalalley.org/wp-content/uploads/2021/02/Marani-Logo-300x116.jpg)
Saluda Medical Expands Executive Leadership Team with Vision for Growth
![](https://medicalalley.org/wp-content/uploads/2019/12/Saluda_Medical_Logo.jpg)
Viewpoint Molecular Targeting® Enters Agreement with UK-Based National Nuclear Laboratory, Ltd. to Advance Development of Targeted Alpha Therapy for Cancer
![](https://medicalalley.org/wp-content/uploads/2021/09/Viewpoint-Molecular-Targeting-300x75.png)
Unique Glioblastoma Treatment Sees Encouraging Early Results During Phase 1 Clinical Trials
![](https://medicalalley.org/wp-content/uploads/2021/01/ox2.png)
Livio Health Names Wendy Wilts as Chief Operating Officer
![](https://medicalalley.org/wp-content/uploads/2021/11/livio-health-300x165.png)
Celcuity Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Provide Ibrance(R) (palbociclib) for Planned Phase 3 Clinical Trial
![](https://medicalalley.org/wp-content/uploads/2018/05/lg_celcuity-pms-300x97.jpg)
Collider Foundation Leader to Join Mayo Clinic’s Platform Initiative
![](https://medicalalley.org/wp-content/uploads/2020/04/Mayo-Clinic-300x78.jpg)
HTEC Group Acquires Momentum Design Lab – Surpassing 1,000 Employees, HTEC fuses Silicon Valley’s Highest-rated Digital Product Design Studio to its Top Engineering Talent
![](https://medicalalley.org/wp-content/uploads/2021/04/HTEC-Group-300x69.png)